| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4180fc57a693864e2ce2dbfd64a9278 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2004-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b241fa63b90e6bef467e972467a5138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c662610552ee015c1afa82642335b86 |
| publicationDate |
2009-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-602004018765-D1 |
| titleOfInvention |
USE OF 2-CYANO-10- (2-METHYL-3- (METHYLAMINO) -PROPYL) -PHENOTHIAZINE OR A PHARMACEUTICAL ACCEPTABLE SALT OF THE MEDICINAL PRODUCT |
| priorityDate |
2003-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |